Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancer
Li et al. report outcomes from the atezolizumab/isatuximab arm of the phase Ib/II MORPHEUS-CRC trial in patients with metastatic colorectal cancer. In addition, the authors leverage historical control data from the phase III IMblaze370 study to provide more precise treatment effect estimates.
Main Authors: | Chen Li, Ana Ferro, Shivani K. Mhatre, Danny Lu, Marcus Lawrance, Xiao Li, Shi Li, Simon Allen, Jayesh Desai, Marwan Fakih, Michael Cecchini, Katrina S. Pedersen, Tae You Kim, Irmarie Reyes-Rivera, Neil H. Segal, Christelle Lenain |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-07-01
|
Series: | Communications Medicine |
Online Access: | https://doi.org/10.1038/s43856-022-00155-y |
Similar Items
-
Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations
by: W. Katherine Tan, et al.
Published: (2022-12-01) -
Trunk extensors endurance with arms parallel to the trunk is superior to other arms positions: randomized- controlled trial
by: Samiha Mohamed Ibrahim Abd Elkader, et al.
Published: (2022-04-01) -
Efficacy of antidepressants over placebo is similar in two-armed versus three-armed or more-armed randomized placebo-controlled trials.
by: Ogawa, Y, et al.
Published: (2017) -
Utilization of anonymization techniques to create an external control arm for clinical trial data
by: Juha Mehtälä, et al.
Published: (2023-11-01) -
Changing trends in phase 1 oncology clinical trials
by: Richard Kelly, et al.
Published: (2024-02-01)